News Daily News Financial Burden of Hypertension Weighs Heavily on US Population Todd Neale May 30, 2018
News Conference News EuroPCR 2018 Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted Caitlin E. Cox May 23, 2018
News Daily News One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI Michael O'Riordan May 21, 2018
News Daily News Skyrocketing Costs of CVD Will Be Amplified by Informal Caregiving: AHA Shelley Wood April 09, 2018
News Daily News Burden of Readmission High in PAD Patients Following Revascularization L.A. McKeown December 04, 2017
News Conference News AHA 2017 Reimbursement Remedy Backfires: Stress Tests Have Shifted From Private Practice to Hospitals, Driving Up Costs Yael L. Maxwell November 16, 2017
News Conference News AHA 2017 One in Eight US Patients With MI or Stroke Under Age 65 Are Uninsured, Face Catastrophic Costs Shelley Wood November 14, 2017
News Daily News Hurricanes and Wildfires Take Their Toll on Prominent CVD Med-Tech Companies Todd Neale October 19, 2017
News Daily News Vast Majority Return to Work After MI, but It Doesn’t Always Stick Todd Neale October 04, 2017
News Industry News Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death October 02, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Daily News Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis Caitlin E. Cox September 14, 2017
News Daily News Improving Echo Appropriateness: Audit and Feedback Intervention Works Todd Neale August 23, 2017
News Daily News Poor Prescription Adherence After Acute MI Continues to Vex Researchers L.A. McKeown June 30, 2017
News Conference News TVT 2017 Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line Michael O'Riordan June 20, 2017
News Daily News Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete? Michael O'Riordan June 05, 2017
News Daily News $2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor Michael O'Riordan May 12, 2017